| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Estrogen Receptor alpha | 19 | 2011 | 577 | 2.250 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 14 | 2016 | 170 | 1.850 |
Why?
|
| Receptors, Estrogen | 16 | 2017 | 2187 | 1.580 |
Why?
|
| Neoplasms, Hormone-Dependent | 14 | 2011 | 415 | 1.560 |
Why?
|
| Receptors, Androgen | 15 | 2011 | 1058 | 1.310 |
Why?
|
| Estrogens | 10 | 2010 | 1566 | 1.020 |
Why?
|
| Response Elements | 5 | 2008 | 312 | 0.830 |
Why?
|
| Gene Expression Regulation, Neoplastic | 19 | 2017 | 8428 | 0.810 |
Why?
|
| Enhancer Elements, Genetic | 8 | 2011 | 1341 | 0.760 |
Why?
|
| Mammary Neoplasms, Experimental | 3 | 2010 | 520 | 0.730 |
Why?
|
| Chromatin Immunoprecipitation | 11 | 2009 | 893 | 0.700 |
Why?
|
| Estradiol | 12 | 2016 | 2020 | 0.620 |
Why?
|
| Nuclear Receptor Coactivator 3 | 5 | 2010 | 53 | 0.600 |
Why?
|
| Breast Neoplasms | 30 | 2022 | 20822 | 0.590 |
Why?
|
| Transcriptional Activation | 6 | 2009 | 1783 | 0.570 |
Why?
|
| Tamoxifen | 6 | 2017 | 981 | 0.570 |
Why?
|
| SOX9 Transcription Factor | 1 | 2017 | 146 | 0.560 |
Why?
|
| Cell Line, Tumor | 37 | 2017 | 16689 | 0.540 |
Why?
|
| Epidermal Growth Factor | 4 | 2016 | 708 | 0.510 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 12 | 2011 | 3920 | 0.510 |
Why?
|
| RNA, Neoplasm | 2 | 2017 | 769 | 0.500 |
Why?
|
| Transcription Factors | 17 | 2011 | 12208 | 0.490 |
Why?
|
| Ribonucleoproteins | 1 | 2017 | 381 | 0.490 |
Why?
|
| Antineoplastic Agents, Hormonal | 8 | 2017 | 1524 | 0.480 |
Why?
|
| Osteoclasts | 2 | 2008 | 729 | 0.470 |
Why?
|
| Transcription, Genetic | 11 | 2009 | 7722 | 0.470 |
Why?
|
| RNA Splicing | 1 | 2017 | 907 | 0.430 |
Why?
|
| Promoter Regions, Genetic | 15 | 2010 | 5867 | 0.420 |
Why?
|
| Histone Acetyltransferases | 5 | 2008 | 336 | 0.410 |
Why?
|
| DNA Polymerase II | 3 | 2009 | 107 | 0.400 |
Why?
|
| Prostatic Neoplasms | 13 | 2017 | 11124 | 0.400 |
Why?
|
| E2F1 Transcription Factor | 2 | 2010 | 190 | 0.390 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2017 | 5172 | 0.380 |
Why?
|
| Fas Ligand Protein | 2 | 2008 | 216 | 0.370 |
Why?
|
| Protein-Arginine N-Methyltransferases | 2 | 2009 | 131 | 0.370 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 1889 | 0.350 |
Why?
|
| Trans-Activators | 5 | 2010 | 2924 | 0.350 |
Why?
|
| Gene Expression Regulation | 10 | 2009 | 12072 | 0.320 |
Why?
|
| Cyclin D1 | 2 | 2009 | 463 | 0.320 |
Why?
|
| Osteoblasts | 3 | 2008 | 1166 | 0.310 |
Why?
|
| Oncogene Proteins | 3 | 2010 | 749 | 0.310 |
Why?
|
| Neoplasm Proteins | 3 | 2018 | 3703 | 0.300 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2009 | 635 | 0.300 |
Why?
|
| Breast | 3 | 2017 | 1969 | 0.300 |
Why?
|
| GATA3 Transcription Factor | 1 | 2007 | 157 | 0.290 |
Why?
|
| Androgens | 7 | 2011 | 1281 | 0.280 |
Why?
|
| Chromosome Mapping | 4 | 2009 | 4740 | 0.270 |
Why?
|
| Histones | 8 | 2011 | 2599 | 0.270 |
Why?
|
| DNA-Binding Proteins | 9 | 2011 | 9648 | 0.260 |
Why?
|
| Epigenesis, Genetic | 5 | 2010 | 3647 | 0.260 |
Why?
|
| Binding Sites | 11 | 2011 | 6114 | 0.260 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2003 | 61 | 0.230 |
Why?
|
| Nuclear Proteins | 5 | 2010 | 5853 | 0.230 |
Why?
|
| Protein Kinases | 2 | 2010 | 1640 | 0.230 |
Why?
|
| Chromosomes, Human | 1 | 2005 | 457 | 0.230 |
Why?
|
| Chromatin | 7 | 2017 | 2934 | 0.220 |
Why?
|
| Models, Biological | 7 | 2010 | 9583 | 0.220 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2010 | 949 | 0.210 |
Why?
|
| Gene Expression Profiling | 13 | 2016 | 9438 | 0.210 |
Why?
|
| Oncogenes | 2 | 2006 | 1265 | 0.210 |
Why?
|
| Genome, Human | 6 | 2010 | 4420 | 0.200 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2003 | 209 | 0.200 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2002 | 129 | 0.200 |
Why?
|
| Cell Proliferation | 9 | 2017 | 10481 | 0.190 |
Why?
|
| Gene Silencing | 6 | 2008 | 1538 | 0.180 |
Why?
|
| Blotting, Western | 6 | 2011 | 5179 | 0.180 |
Why?
|
| Diet | 1 | 2018 | 7939 | 0.180 |
Why?
|
| Genome-Wide Association Study | 2 | 2017 | 12261 | 0.180 |
Why?
|
| Repressor Proteins | 4 | 2008 | 3023 | 0.170 |
Why?
|
| Endometrium | 1 | 2002 | 424 | 0.170 |
Why?
|
| Tumor Cells, Cultured | 5 | 2009 | 6314 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2010 | 4751 | 0.160 |
Why?
|
| Osteoporosis | 1 | 2008 | 1580 | 0.160 |
Why?
|
| Receptors, Progesterone | 4 | 2011 | 1097 | 0.160 |
Why?
|
| Homeodomain Proteins | 4 | 2011 | 2421 | 0.160 |
Why?
|
| Protein Binding | 7 | 2009 | 9386 | 0.150 |
Why?
|
| Humans | 71 | 2022 | 744343 | 0.150 |
Why?
|
| Carcinoma | 1 | 2009 | 2375 | 0.150 |
Why?
|
| Bone and Bones | 1 | 2008 | 2575 | 0.150 |
Why?
|
| Nucleosomes | 2 | 2011 | 494 | 0.140 |
Why?
|
| RNA Polymerase II | 3 | 2007 | 551 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2009 | 2915 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2010 | 987 | 0.140 |
Why?
|
| Thyroid Neoplasms | 1 | 2009 | 2282 | 0.130 |
Why?
|
| Genomics | 2 | 2009 | 5720 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2010 | 2503 | 0.130 |
Why?
|
| Cell Cycle | 4 | 2006 | 2967 | 0.130 |
Why?
|
| Transfection | 6 | 2009 | 5892 | 0.130 |
Why?
|
| Melanoma, Experimental | 1 | 2018 | 561 | 0.130 |
Why?
|
| Models, Genetic | 6 | 2011 | 3494 | 0.130 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 2 | 2005 | 28 | 0.120 |
Why?
|
| Adenocarcinoma | 3 | 2011 | 6364 | 0.120 |
Why?
|
| Conserved Sequence | 2 | 2009 | 1202 | 0.120 |
Why?
|
| Receptor, erbB-2 | 3 | 2022 | 2416 | 0.110 |
Why?
|
| Tissue Distribution | 3 | 2008 | 2327 | 0.110 |
Why?
|
| Dihydrotestosterone | 4 | 2011 | 190 | 0.110 |
Why?
|
| Organ Specificity | 3 | 2010 | 2008 | 0.110 |
Why?
|
| Cytokines | 1 | 2008 | 7322 | 0.110 |
Why?
|
| Nuclear Receptor Coactivator 2 | 2 | 2002 | 37 | 0.110 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2002 | 1888 | 0.100 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 713 | 0.100 |
Why?
|
| Acetyltransferases | 2 | 2004 | 234 | 0.100 |
Why?
|
| Mice, Transgenic | 4 | 2010 | 9734 | 0.100 |
Why?
|
| Cell Survival | 5 | 2008 | 5882 | 0.100 |
Why?
|
| RNA, Small Interfering | 4 | 2010 | 3505 | 0.100 |
Why?
|
| Organic Anion Transporters, Sodium-Independent | 1 | 2011 | 24 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2002 | 2942 | 0.100 |
Why?
|
| Cell Line | 7 | 2011 | 15997 | 0.100 |
Why?
|
| Mice | 13 | 2018 | 81183 | 0.100 |
Why?
|
| Genetic Complementation Test | 2 | 2010 | 562 | 0.100 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 3 | 2010 | 794 | 0.100 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2010 | 31 | 0.100 |
Why?
|
| Mice, Knockout | 4 | 2010 | 14557 | 0.090 |
Why?
|
| Organic Anion Transporters | 1 | 2011 | 100 | 0.090 |
Why?
|
| Androgen Antagonists | 3 | 2011 | 1377 | 0.090 |
Why?
|
| Female | 25 | 2022 | 380194 | 0.090 |
Why?
|
| Signal Transduction | 10 | 2016 | 23403 | 0.090 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2009 | 43 | 0.090 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2009 | 86 | 0.090 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2010 | 504 | 0.090 |
Why?
|
| Membrane Proteins | 2 | 2006 | 7880 | 0.080 |
Why?
|
| Lymphangioleiomyomatosis | 1 | 2011 | 210 | 0.080 |
Why?
|
| Orchiectomy | 1 | 2011 | 474 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2011 | 1213 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 491 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 489 | 0.080 |
Why?
|
| PAX2 Transcription Factor | 1 | 2008 | 80 | 0.080 |
Why?
|
| Integrin alpha6 | 1 | 2008 | 30 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2002 | 5021 | 0.080 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2009 | 195 | 0.080 |
Why?
|
| Methylation | 2 | 2009 | 1106 | 0.080 |
Why?
|
| Epigenomics | 2 | 2011 | 903 | 0.080 |
Why?
|
| Tacrolimus Binding Proteins | 2 | 2010 | 195 | 0.080 |
Why?
|
| Histone Demethylases | 1 | 2011 | 321 | 0.080 |
Why?
|
| Cell Division | 2 | 2009 | 4568 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2010 | 460 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 323 | 0.080 |
Why?
|
| Genes, erbB-2 | 1 | 2008 | 162 | 0.080 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2009 | 198 | 0.080 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2010 | 315 | 0.080 |
Why?
|
| Glucuronosyltransferase | 1 | 2008 | 128 | 0.080 |
Why?
|
| Progestins | 1 | 2010 | 306 | 0.080 |
Why?
|
| Animals | 14 | 2018 | 168757 | 0.080 |
Why?
|
| Cell Differentiation | 4 | 2011 | 11483 | 0.080 |
Why?
|
| Ovariectomy | 1 | 2010 | 661 | 0.080 |
Why?
|
| Flow Cytometry | 2 | 2009 | 5974 | 0.080 |
Why?
|
| Tissue Array Analysis | 1 | 2009 | 553 | 0.070 |
Why?
|
| Estrogen Receptor beta | 1 | 2008 | 175 | 0.070 |
Why?
|
| Luciferases | 2 | 2009 | 733 | 0.070 |
Why?
|
| Lipids | 1 | 2018 | 3305 | 0.070 |
Why?
|
| Histone Code | 1 | 2008 | 163 | 0.070 |
Why?
|
| Insulin | 1 | 2002 | 6580 | 0.070 |
Why?
|
| Proteins | 1 | 2002 | 6103 | 0.070 |
Why?
|
| NFI Transcription Factors | 1 | 2006 | 44 | 0.070 |
Why?
|
| Gonadotropin-Releasing Hormone | 2 | 2011 | 1205 | 0.070 |
Why?
|
| Software | 3 | 2011 | 4443 | 0.070 |
Why?
|
| Immunohistochemistry | 3 | 2011 | 11366 | 0.070 |
Why?
|
| 3T3 Cells | 1 | 2008 | 1101 | 0.070 |
Why?
|
| Transcription Initiation Site | 1 | 2006 | 196 | 0.070 |
Why?
|
| Neoplasms, Basal Cell | 1 | 2006 | 31 | 0.070 |
Why?
|
| RNA, Messenger | 6 | 2010 | 13033 | 0.070 |
Why?
|
| Endometrial Hyperplasia | 1 | 2006 | 97 | 0.070 |
Why?
|
| Immunoblotting | 2 | 2009 | 1682 | 0.070 |
Why?
|
| Cell Movement | 4 | 2010 | 5217 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2006 | 2916 | 0.070 |
Why?
|
| beta Catenin | 1 | 2011 | 1059 | 0.070 |
Why?
|
| Genome | 3 | 2010 | 1808 | 0.070 |
Why?
|
| Down-Regulation | 3 | 2009 | 3002 | 0.070 |
Why?
|
| Ligands | 2 | 2003 | 3282 | 0.070 |
Why?
|
| G1 Phase | 1 | 2006 | 415 | 0.060 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2005 | 32 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2004 | 2015 | 0.060 |
Why?
|
| Alkaline Phosphatase | 1 | 2008 | 865 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2005 | 230 | 0.060 |
Why?
|
| Oligonucleotides | 1 | 2008 | 572 | 0.060 |
Why?
|
| Gene Dosage | 1 | 2009 | 1252 | 0.060 |
Why?
|
| Epithelial Cells | 3 | 2010 | 3690 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2005 | 351 | 0.060 |
Why?
|
| beta-Naphthoflavone | 1 | 2003 | 5 | 0.060 |
Why?
|
| Chromosomes, Human, X | 1 | 2006 | 296 | 0.060 |
Why?
|
| Receptors, CXCR4 | 1 | 2009 | 726 | 0.060 |
Why?
|
| Neurons | 2 | 2011 | 9338 | 0.060 |
Why?
|
| Estrogen Antagonists | 1 | 2004 | 152 | 0.060 |
Why?
|
| beta-Galactosidase | 1 | 2005 | 573 | 0.060 |
Why?
|
| Coculture Techniques | 1 | 2008 | 1341 | 0.060 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2003 | 91 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2010 | 3701 | 0.060 |
Why?
|
| Microarray Analysis | 1 | 2006 | 767 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2006 | 10943 | 0.060 |
Why?
|
| Molecular Sequence Data | 5 | 2010 | 18111 | 0.060 |
Why?
|
| RNA Interference | 3 | 2009 | 2889 | 0.060 |
Why?
|
| DNA, Neoplasm | 1 | 2008 | 1758 | 0.060 |
Why?
|
| MicroRNAs | 2 | 2009 | 3752 | 0.060 |
Why?
|
| Male | 17 | 2017 | 350118 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2011 | 21827 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2009 | 2649 | 0.050 |
Why?
|
| Mammary Glands, Animal | 1 | 2004 | 276 | 0.050 |
Why?
|
| Algorithms | 3 | 2008 | 13881 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2018 | 4445 | 0.050 |
Why?
|
| Liver | 1 | 2018 | 7474 | 0.050 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2002 | 42 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2004 | 430 | 0.050 |
Why?
|
| Apoptosis | 2 | 2009 | 9727 | 0.050 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2005 | 434 | 0.050 |
Why?
|
| Gene Expression | 4 | 2009 | 7799 | 0.050 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2002 | 59 | 0.050 |
Why?
|
| Aromatase | 1 | 2002 | 146 | 0.050 |
Why?
|
| Colonic Neoplasms | 2 | 2010 | 2541 | 0.050 |
Why?
|
| Intestines | 1 | 2010 | 1924 | 0.050 |
Why?
|
| Microfilament Proteins | 1 | 2006 | 1152 | 0.050 |
Why?
|
| Endopeptidases | 1 | 2004 | 772 | 0.050 |
Why?
|
| Genes, myc | 1 | 2002 | 399 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2009 | 1708 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2022 | 8863 | 0.050 |
Why?
|
| Cell Line, Transformed | 1 | 2002 | 898 | 0.050 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2008 | 1581 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2006 | 4320 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2009 | 2504 | 0.040 |
Why?
|
| Caco-2 Cells | 2 | 2010 | 387 | 0.040 |
Why?
|
| Precancerous Conditions | 1 | 2006 | 975 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 2002 | 1454 | 0.040 |
Why?
|
| Sirolimus | 1 | 2006 | 1564 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 3617 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2010 | 3036 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2008 | 2499 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2006 | 1813 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2022 | 705 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2008 | 6386 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 13695 | 0.040 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 2008 | 1052 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2022 | 538 | 0.040 |
Why?
|
| Cell Growth Processes | 2 | 2009 | 399 | 0.040 |
Why?
|
| Base Sequence | 4 | 2010 | 12797 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2002 | 1950 | 0.040 |
Why?
|
| Homeostasis | 1 | 2009 | 3340 | 0.040 |
Why?
|
| DNA | 2 | 2008 | 7301 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2008 | 4026 | 0.040 |
Why?
|
| Dioxygenases | 2 | 2009 | 316 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2006 | 2109 | 0.040 |
Why?
|
| Histone Deacetylases | 1 | 2002 | 728 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2002 | 1097 | 0.040 |
Why?
|
| Prostate | 1 | 2005 | 1774 | 0.040 |
Why?
|
| Serpins | 1 | 2018 | 247 | 0.040 |
Why?
|
| Telomerase | 1 | 2002 | 730 | 0.040 |
Why?
|
| Transcription Factor AP-2 | 1 | 2016 | 82 | 0.030 |
Why?
|
| Obesity | 1 | 2018 | 12745 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2003 | 3798 | 0.030 |
Why?
|
| Prostate-Specific Antigen | 1 | 2005 | 2494 | 0.030 |
Why?
|
| Indoles | 1 | 2003 | 1839 | 0.030 |
Why?
|
| Bone Density | 1 | 2008 | 3468 | 0.030 |
Why?
|
| Polymorphism, Genetic | 2 | 2002 | 4328 | 0.030 |
Why?
|
| Biological Transport | 2 | 2011 | 2118 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2006 | 3589 | 0.030 |
Why?
|
| Protein Isoforms | 2 | 2010 | 1730 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2006 | 4149 | 0.030 |
Why?
|
| Nitriles | 2 | 2009 | 956 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 3772 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2016 | 6895 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2009 | 3128 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2002 | 2440 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 1038 | 0.030 |
Why?
|
| Endometrial Neoplasms | 1 | 2002 | 1353 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2010 | 40561 | 0.030 |
Why?
|
| Incidence | 1 | 2010 | 20947 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 15519 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2002 | 2849 | 0.020 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2018 | 1821 | 0.020 |
Why?
|
| GATA6 Transcription Factor | 1 | 2010 | 50 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2006 | 19229 | 0.020 |
Why?
|
| Promegestone | 1 | 2010 | 9 | 0.020 |
Why?
|
| Plicamycin | 1 | 2010 | 13 | 0.020 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2010 | 32 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2010 | 118 | 0.020 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2011 | 238 | 0.020 |
Why?
|
| Cell Adhesion | 2 | 2008 | 3144 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 13815 | 0.020 |
Why?
|
| GA-Binding Protein Transcription Factor | 1 | 2009 | 46 | 0.020 |
Why?
|
| Angiomyolipoma | 1 | 2011 | 190 | 0.020 |
Why?
|
| Serum Response Factor | 1 | 2009 | 81 | 0.020 |
Why?
|
| Neoplasm Metastasis | 2 | 2010 | 4851 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 4554 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 480 | 0.020 |
Why?
|
| Cell Nucleus | 2 | 2010 | 2969 | 0.020 |
Why?
|
| Tosyl Compounds | 1 | 2009 | 113 | 0.020 |
Why?
|
| E2F Transcription Factors | 1 | 2009 | 277 | 0.020 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2009 | 115 | 0.020 |
Why?
|
| Arabidopsis Proteins | 1 | 2010 | 262 | 0.020 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2009 | 186 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2010 | 514 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2009 | 743 | 0.020 |
Why?
|
| Propionates | 1 | 2008 | 169 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2011 | 57776 | 0.020 |
Why?
|
| Melanocytes | 1 | 2011 | 515 | 0.020 |
Why?
|
| Phosphorylcholine | 1 | 2008 | 162 | 0.020 |
Why?
|
| Androgen Receptor Antagonists | 1 | 2008 | 114 | 0.020 |
Why?
|
| Ribonuclease III | 1 | 2009 | 275 | 0.020 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2008 | 298 | 0.020 |
Why?
|
| Postmenopause | 1 | 2016 | 2461 | 0.020 |
Why?
|
| Chemokine CXCL12 | 1 | 2009 | 464 | 0.020 |
Why?
|
| Mammary Glands, Human | 1 | 2008 | 199 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2011 | 13102 | 0.020 |
Why?
|
| Anoikis | 1 | 2006 | 49 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2010 | 721 | 0.020 |
Why?
|
| Uniparental Disomy | 1 | 2006 | 43 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 3586 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2010 | 704 | 0.020 |
Why?
|
| Anilides | 1 | 2009 | 408 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2010 | 1726 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2010 | 871 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 1655 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2010 | 1547 | 0.020 |
Why?
|
| Genes, X-Linked | 1 | 2006 | 128 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2006 | 299 | 0.020 |
Why?
|
| Sweden | 1 | 2008 | 1345 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2018 | 4479 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2010 | 1285 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2008 | 2050 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2011 | 1504 | 0.020 |
Why?
|
| DNA Methylation | 2 | 2011 | 4286 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2006 | 437 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2009 | 742 | 0.020 |
Why?
|
| Phenols | 1 | 2008 | 497 | 0.020 |
Why?
|
| Phenotype | 1 | 2002 | 16365 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2008 | 1654 | 0.010 |
Why?
|
| Middle Aged | 4 | 2016 | 213383 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2008 | 1792 | 0.010 |
Why?
|
| Boronic Acids | 1 | 2008 | 965 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2010 | 1526 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 40075 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2011 | 2751 | 0.010 |
Why?
|
| Disease Progression | 2 | 2011 | 13284 | 0.010 |
Why?
|
| Tuberous Sclerosis | 1 | 2011 | 1029 | 0.010 |
Why?
|
| Alleles | 2 | 2006 | 6933 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 2008 | 1072 | 0.010 |
Why?
|
| Pregnancy | 1 | 2004 | 29144 | 0.010 |
Why?
|
| Genotype | 2 | 2011 | 12951 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2011 | 4186 | 0.010 |
Why?
|
| RNA, Untranslated | 1 | 2006 | 453 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 1312 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2016 | 12026 | 0.010 |
Why?
|
| Keratinocytes | 1 | 2006 | 798 | 0.010 |
Why?
|
| Pyrazines | 1 | 2008 | 1230 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2009 | 1678 | 0.010 |
Why?
|
| CpG Islands | 1 | 2006 | 1172 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2008 | 3689 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2010 | 4217 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 9274 | 0.010 |
Why?
|
| Genetic Loci | 1 | 2010 | 2575 | 0.010 |
Why?
|
| Testosterone | 1 | 2011 | 2420 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 6538 | 0.010 |
Why?
|
| Aged | 2 | 2011 | 163280 | 0.010 |
Why?
|
| Adult | 3 | 2011 | 214055 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2008 | 3616 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2008 | 2382 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2002 | 798 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2011 | 8436 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 18029 | 0.010 |
Why?
|
| BRCA1 Protein | 1 | 2006 | 1149 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 6171 | 0.010 |
Why?
|
| Health Surveys | 1 | 2008 | 4037 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2008 | 1972 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2009 | 3462 | 0.010 |
Why?
|
| Hormone Replacement Therapy | 1 | 2002 | 745 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2003 | 63114 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2002 | 2924 | 0.010 |
Why?
|
| Brachytherapy | 1 | 2002 | 1248 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 2011 | 4262 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2002 | 4933 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2002 | 21746 | 0.010 |
Why?
|
| Internet | 1 | 2006 | 3064 | 0.010 |
Why?
|
| Prostatectomy | 1 | 2002 | 1890 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2002 | 2455 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2002 | 6459 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2009 | 9239 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2002 | 8642 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 7913 | 0.010 |
Why?
|
| Physicians | 1 | 2008 | 4567 | 0.010 |
Why?
|
| Risk Factors | 2 | 2010 | 72290 | 0.010 |
Why?
|
| Prognosis | 1 | 2010 | 29063 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2002 | 11031 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 11524 | 0.000 |
Why?
|
| Quality of Life | 1 | 2002 | 12804 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 17446 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2002 | 53288 | 0.000 |
Why?
|